Marianna Koczywas

Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Apar Kishor Ganti, Billy W. Loo, M. Bassetti et al. · Journal of the National Comprehensive Cancer Network · 2021 · 431 citations · Full text

Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer

Daneng Li, Can‐Lan Sun, Heeyoung Kim et al. · JAMA Oncology · 2021 · 419 citations · Full text

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH)

Solange Peters, Scott Gettinger, Melissa L. Johnson et al. · Journal of Clinical Oncology · 2017 · 415 citations · Full text

NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018

Gregory P. Kalemkerian, Billy W. Loo, Wallace Akerley et al. · Journal of the National Comprehensive Cancer Network · 2018 · 294 citations · Full text

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel et al. · Journal of Clinical Oncology · 2009 · 267 citations

Purpose Vorinostat, Advanced Nsclc, First-line Therapy +12